Variant Bio Launches Inference, the World's First Agentic AI Genomic Drug Discovery Platform

Variant Bio, a genomics-driven AI drug discovery company, today announced the launch of Inference, the world's first agentic genomic drug dis ...
Business Wire

Manifold Bio Raises $40 Million Series A to Expand In Vivo Biologics Design Platform

BOSTON--(BUSINESS WIRE)--Manifold Bio, a next-generation protein therapeutics company pioneering an in vivo biologics design platform, today announced the close of a $40 million Series A financing ...
Forbes

From Silicon To Water: The Liquid, Bio-Inspired Future Of Data Centers

For many years, the landscape of data center innovation has been dominated by solid-state electronics. The relentless pursuit of faster chips, denser racks and larger facilities has been the mantra ...
Forbes

How To Ensure Fair, Safe AI Through Thoughtful Data Design

AI systems are only as fair and safe as the data they’re built on. While conversations about AI ethics often focus on model architecture, algorithmic transparency or deployment oversight, fairness and ...